H.C. Wainwright analyst Vernon Bernardino initiated coverage with a Buy rating on Blue Water Vaccines, Inc. (BWV - Research Report) today and set a price target of $7.00. The company's shares closed yesterday at $1.16.According to TipRanks, Bernardino is a 5-star analyst with an average return of 16.9% and a 31.18% success rate. Bernardino covers the Healthcare sector, focusing on stocks such as Phio Pharmaceuticals, GeoVax Labs, and Seres Therapeutics.Blue Water Vaccines, Inc. has an analyst consensus of Moderate Buy, with a price target consensus of $5.50, a 374.14% upside from current levels.
https://www.tipranks.com/news/blurbs/blue-water-vaccines-inc-bwv-gets-a-buy-from-h-c-wainwright?utm_source=advfn.com&utm_medium=referral
Blue Water Biotech (NASDAQ:BWV)
Historical Stock Chart
From May 2023 to Jun 2023 Click Here for more Blue Water Biotech Charts.
Blue Water Biotech (NASDAQ:BWV)
Historical Stock Chart
From Jun 2022 to Jun 2023 Click Here for more Blue Water Biotech Charts.